SCHEMBL30784396

SCHEMBL30784396

CC(N)c1cc(F)cc2c(=O)n(C)c(N3CCOCC3)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ PIK3CB P42338 4/20 0.37
▸ AKT1 P31749 1/20 0.36
▸ AKT2 P31751 1/20 0.36
▸ AKT3 Q9Y243 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ PTPN11 Q06124 2/20 0.35
▸ LMNA P02545 1/20 0.34
▸ STAT6 P42226 1/20 0.34
▸ DPP4 P27487 1/20 0.34
▸ TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783830 1.00 HTT (0.39) HTTCYP1A2KMT2ADRD2DRD4
SCHEMBL30783794 0.90 HTT (0.40) HTTCYP1A2KMT2ADRD2DRD4
SCHEMBL30783583 0.88 AKT1 (0.47) HTTKMT2ADRD2DRD4DRD3
SCHEMBL30784348 0.88 AKT1 (0.47) HTTKMT2ADRD2DRD4DRD3
SCHEMBL30784294 0.87 PIK3CB (0.36) CYP1A2PIK3CBAKT1SMN1; SMN2RAB9A
SCHEMBL26041490 0.87 AKT1 (0.42) AKT1AKT2AKT3PTPN11KDM1A
SCHEMBL30784172 0.87 HTT (0.39) HTTCYP1A2KMT2ADRD2DRD4
SCHEMBL30783695 0.87 HTT (0.39) HTTKMT2ADRD2DRD4DRD3
SCHEMBL30784462 0.86 SOS1 (0.42) HTTKMT2ADRD2DRD4DRD3
SCHEMBL30784328 0.85 DPP4 (0.39) HTTCYP1A2KMT2ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback